Intuitive Surgical (NASDAQ:ISRG) Releases Earnings Results, Beats Expectations By $0.10 EPS

Intuitive Surgical (NASDAQ:ISRG) released its earnings results on Thursday. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10, Briefing.com reports. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same period in the prior year, the firm posted $1.00 earnings per share. The company’s quarterly revenue was up 11.5% on a year-over-year basis.

Intuitive Surgical Stock Down 0.4 %

NASDAQ ISRG opened at $372.63 on Friday. The stock’s 50-day moving average price is $387.27 and its 200-day moving average price is $342.60. Intuitive Surgical has a 52 week low of $254.85 and a 52 week high of $403.76. The company has a market capitalization of $132.08 billion, a P/E ratio of 74.08, a price-to-earnings-growth ratio of 5.81 and a beta of 1.36.

Insider Transactions at Intuitive Surgical

In related news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the sale, the vice president now owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the sale, the executive vice president now owns 189 shares of the company’s stock, valued at approximately $69,958.35. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the sale, the vice president now directly owns 26,877 shares in the company, valued at approximately $10,349,795.16. The disclosure for this sale can be found here. Insiders have sold 248,418 shares of company stock valued at $95,927,097 over the last quarter. 0.90% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

A number of large investors have recently added to or reduced their stakes in the company. O Dell Group LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $30,000. PCA Investment Advisory Services Inc. purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $35,000. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of Intuitive Surgical by 176.2% in the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 116 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 74 shares during the period. Cornerstone Planning Group LLC purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $51,000. Finally, Strategic Investment Solutions Inc. IL purchased a new position in shares of Intuitive Surgical in the 1st quarter worth approximately $39,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ISRG. Piper Sandler increased their target price on Intuitive Surgical from $325.00 to $425.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 24th. Barclays increased their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. Truist Financial increased their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Citigroup increased their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, Wells Fargo & Company increased their price objective on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Five equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $375.70.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.